Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.
Feld JJ, Modi AA, El-Diwany R, Rotman Y, Thomas E, Ahlenstiel G, Titerence R, Koh C, Cherepanov V, Heller T, Ghany MG, Park Y, Hoofnagle JH, Liang TJ. Feld JJ, et al. Among authors: cherepanov v. Gastroenterology. 2011 Mar;140(3):830-9. doi: 10.1053/j.gastro.2010.09.010. Epub 2010 Sep 17. Gastroenterology. 2011. PMID: 20854821 Free PMC article. Clinical Trial.
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.
Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, Sherker A, Petoumenos K, Zang G, Shaw I, Yeung B, George J, Teutsch S, Kaldor JM, Cherepanov V, Bruneau J, Shoukry NH, Lloyd AR, Dore GJ. Grebely J, et al. Among authors: cherepanov v. Hepatology. 2013 Jun;57(6):2124-34. doi: 10.1002/hep.26263. Epub 2013 May 8. Hepatology. 2013. PMID: 23325615 Free PMC article. Clinical Trial.
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection.
Feld JJ, Grebely J, Matthews GV, Applegate T, Hellard M, Sherker A, Cherepanov V, Petoumenos K, Yeung B, Kaldor JM, Lloyd AR, Dore GJ. Feld JJ, et al. Among authors: cherepanov v. PLoS One. 2013 Nov 20;8(11):e80003. doi: 10.1371/journal.pone.0080003. eCollection 2013. PLoS One. 2013. PMID: 24278230 Free PMC article.
Inducing Hepatitis C Virus Resistance After Pig Liver Transplantation-A Proof of Concept of Liver Graft Modification Using Warm Ex Vivo Perfusion.
Goldaracena N, Spetzler VN, Echeverri J, Kaths JM, Cherepanov V, Persson R, Hodges MR, Janssen HL, Selzner N, Grant DR, Feld JJ, Selzner M. Goldaracena N, et al. Among authors: cherepanov v. Am J Transplant. 2017 Apr;17(4):970-978. doi: 10.1111/ajt.14100. Epub 2016 Dec 23. Am J Transplant. 2017. PMID: 27805315 Free article.
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.
Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M. Galasso M, et al. Among authors: cherepanov v. Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z. Nat Commun. 2019. PMID: 30696822 Free PMC article.
Hepatitis C Core-Antigen Testing from Dried Blood Spots.
Biondi MJ, van Tilborg M, Smookler D, Heymann G, Aquino A, Perusini S, Mandel E, Kozak RA, Cherepanov V, Kowgier M, Hansen B, Goneau LW, Janssen HLA, Mazzulli T, Cloherty G, de Knegt RJ, Feld JJ. Biondi MJ, et al. Among authors: cherepanov v. Viruses. 2019 Sep 6;11(9):830. doi: 10.3390/v11090830. Viruses. 2019. PMID: 31489933 Free PMC article.
356 results